Lycia Therapeutics, Inc. (LYCA) stock
LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)
Close on Nov 18, 2026Market cap –P/E –Yield –
Earnings
No earnings reports from Lycia Therapeutics yet
Quarterly results appear here once Lycia Therapeutics files an earnings release with the SEC (Form 8-K, Item 2.02, or Form 6-K).
See a number that looks wrong?